(4S,9aR)-4-cyclopropyl-8-(2-methyl-5-pyrazol-1-ylphenyl)sulfonyl-3,4,6,7,9,9a-hexahydro-1H-pyrazino[2,1-c][1,4]oxazine

C20H26N4O3S — CID 155493257

IUPAC(4S,9aR)-4-cyclopropyl-8-(2-methyl-5-pyrazol-1-ylphenyl)sulfonyl-3,4,6,7,9,9a-hexahydro-1H-pyrazino[2,1-c][1,4]oxazine
SMILESCc1ccc(-n2cccn2)cc1S(=O)(=O)N1CCN2[C@@H](COC[C@@H]2C2CC2)C1
InChIInChI=1S/C20H26N4O3S/c1-15-3-6-17(24-8-2-7-21-24)11-20(15)28(25,26)22-9-10-23-18(12-22)13-27-14-19(23)16-4-5-16/h2-3,6-8,11,16,18-19H,4-5,9-10,12-14H2,1H3/t18-,19-/m1/s1
InChIKeyCJIGNNKZDOWARF-RTBURBONSA-N
MW402.52 g/mol
LogP1.66
Rot. Bonds4

About (4S,9aR)-4-cyclopropyl-8-(2-methyl-5-pyrazol-1-ylphenyl)sulfonyl-3,4,6,7,9,9a-hexahydro-1H-pyrazino[2,1-c][1,4]oxazine

(4S,9aR)-4-cyclopropyl-8-(2-methyl-5-pyrazol-1-ylphenyl)sulfonyl-3,4,6,7,9,9a-hexahydro-1H-pyrazino[2,1-c][1,4]oxazine (PubChem CID 155493257) has the molecular formula C20H26N4O3S and a molecular weight of 402.52 g/mol. Its IUPAC name is (4S,9aR)-4-cyclopropyl-8-(2-methyl-5-pyrazol-1-ylphenyl)sulfonyl-3,4,6,7,9,9a-hexahydro-1H-pyrazino[2,1-c][1,4]oxazine.

Molecular Properties

Compound Name(4S,9aR)-4-cyclopropyl-8-(2-methyl-5-pyrazol-1-ylphenyl)sulfonyl-3,4,6,7,9,9a-hexahydro-1H-pyrazino[2,1-c][1,4]oxazine
PubChem CID155493257
Molecular FormulaC20H26N4O3S
Molecular Weight402.52 g/mol
Exact Mass402.17
IUPAC Name(4S,9aR)-4-cyclopropyl-8-(2-methyl-5-pyrazol-1-ylphenyl)sulfonyl-3,4,6,7,9,9a-hexahydro-1H-pyrazino[2,1-c][1,4]oxazine
SMILESCc1ccc(-n2cccn2)cc1S(=O)(=O)N1CCN2[C@@H](COC[C@@H]2C2CC2)C1
InChIInChI=1S/C20H26N4O3S/c1-15-3-6-17(24-8-2-7-21-24)11-20(15)28(25,26)22-9-10-23-18(12-22)13-27-14-19(23)16-4-5-16/h2-3,6-8,11,16,18-19H,4-5,9-10,12-14H2,1H3/t18-,19-/m1/s1
InChIKeyCJIGNNKZDOWARF-RTBURBONSA-N
XLogP1.66
TPSA67.67 Ų
H-Bond Donors
H-Bond Acceptors6
Rotatable Bonds4
Heavy Atoms28
Complexity

Lipinski Rule of Five

Passes Rule of Five

RuleValue
MW ≤ 500402.52
LogP ≤ 51.66
H-Bond Donors ≤ 50
H-Bond Acceptors ≤ 106

Analyze (4S,9aR)-4-cyclopropyl-8-(2-methyl-5-pyrazol-1-ylphenyl)sulfonyl-3,4,6,7,9,9a-hexahydro-1H-pyrazino[2,1-c][1,4]oxazine with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Frequently Asked Questions

What is the IUPAC name of (4S,9aR)-4-cyclopropyl-8-(2-methyl-5-pyrazol-1-ylphenyl)sulfonyl-3,4,6,7,9,9a-hexahydro-1H-pyrazino[2,1-c][1,4]oxazine?
The IUPAC name of (4S,9aR)-4-cyclopropyl-8-(2-methyl-5-pyrazol-1-ylphenyl)sulfonyl-3,4,6,7,9,9a-hexahydro-1H-pyrazino[2,1-c][1,4]oxazine (CID 155493257) is (4S,9aR)-4-cyclopropyl-8-(2-methyl-5-pyrazol-1-ylphenyl)sulfonyl-3,4,6,7,9,9a-hexahydro-1H-pyrazino[2,1-c][1,4]oxazine.
What is the SMILES notation for (4S,9aR)-4-cyclopropyl-8-(2-methyl-5-pyrazol-1-ylphenyl)sulfonyl-3,4,6,7,9,9a-hexahydro-1H-pyrazino[2,1-c][1,4]oxazine?
The canonical SMILES for (4S,9aR)-4-cyclopropyl-8-(2-methyl-5-pyrazol-1-ylphenyl)sulfonyl-3,4,6,7,9,9a-hexahydro-1H-pyrazino[2,1-c][1,4]oxazine is Cc1ccc(-n2cccn2)cc1S(=O)(=O)N1CCN2[C@@H](COC[C@@H]2C2CC2)C1.
What is the InChIKey of (4S,9aR)-4-cyclopropyl-8-(2-methyl-5-pyrazol-1-ylphenyl)sulfonyl-3,4,6,7,9,9a-hexahydro-1H-pyrazino[2,1-c][1,4]oxazine?
The InChIKey is CJIGNNKZDOWARF-RTBURBONSA-N. The full InChI is InChI=1S/C20H26N4O3S/c1-15-3-6-17(24-8-2-7-21-24)11-20(15)28(25,26)22-9-10-23-18(12-22)13-27-14-19(23)16-4-5-16/h2-3,6-8,11,16,18-19H,4-5,9-10,12-14H2,1H3/t18-,19-/m1/s1.
What are the key properties of (4S,9aR)-4-cyclopropyl-8-(2-methyl-5-pyrazol-1-ylphenyl)sulfonyl-3,4,6,7,9,9a-hexahydro-1H-pyrazino[2,1-c][1,4]oxazine?
(4S,9aR)-4-cyclopropyl-8-(2-methyl-5-pyrazol-1-ylphenyl)sulfonyl-3,4,6,7,9,9a-hexahydro-1H-pyrazino[2,1-c][1,4]oxazine has a molecular weight of 402.52 g/mol, XLogP of 1.66, 4 rotatable bonds, 0 hydrogen bond donors, and 6 hydrogen bond acceptors.
Where does this data come from?
All data for (4S,9aR)-4-cyclopropyl-8-(2-methyl-5-pyrazol-1-ylphenyl)sulfonyl-3,4,6,7,9,9a-hexahydro-1H-pyrazino[2,1-c][1,4]oxazine is sourced from PubChem (CID 155493257), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).